The European MCL Network has released the R-HAD MCL 2005-01 study for relapsed or refractory MCL. In this phase III study the effect of bortezomib in combination with a salvage regimen containing Rituximab, HighDose Cytarabine and Dexamethasone is tested.
read more

01.01.2011: First results of MCL Younger presented at ASH 2010

High dose ARA-C in addition to R-CHOP+ASCT increases significantly complete response rates and TTF
read more

01.01.2011: Molecular Research: R-CHOP/R-DHAP Compared to R-CHOP Induction Followed by High Dose Therapy with Autologous Stem Cell Transplantation Induces Higher Rates of Molecular Remission In MCL

Molecular remission: R-CHOP/R-DHAP superior to R-CHOP concerning molecular remissions (ASH 2010)
read more

11.09.2006: English version Website of European MCL launches.

The English version of the new European MCL Network website has been launched.
read more